Cantor Fitzgerald, L. P. »

Enliven Therapeutics shares owned by Cantor Fitzgerald, L. P.

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Cantor Fitzgerald, L. P. from 13F filings

Historical chart of Cantor Fitzgerald, L. P. investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Cantor Fitzgerald, L. P. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Cantor Fitzgerald, L. P.

Quarter filed Position value Share count Share price at filing
2024-09-30 $845k 33k 25.54

More positions owned by Cantor Fitzgerald, L. P.

Spdr S&p 500 Etf Tr Put Put Option
Nvidia Corporation Put Put Option
Tesla Put Put Option
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Call Call Option
Tesla Motors (TSLA)
Nvidia Corporation Call Call Option
Gcm Grosvenor Com Cl A (GCMG)
Rumble Com Cl A (RUM)
Tesla Call Call Option
Proshares Tr Ultrapro Qqq (TQQQ)
Super Micro Computer Put Put Option
Broadcom Put Put Option
Super Micro Computer (SMCI)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)

View all positions for Cantor Fitzgerald, L. P.

Top funds holding Enliven Therapeutics

OrbiMed Advisors
Commodore Capital
VR Adviser
Fairmount Funds Management
BlackRock
BlackRock
Vanguard Group
5AM Venture Management
Citadel Advisors
RA Capital Management
Pictet Asset Management Holding SA
Woodline Partners
Soleus Capital Management
Geode Capital Management
Henderson Group

View all funds holding Enliven Therapeutics